Market Cap

Genus plc Market Capitalization:

£1.14 Billion

GBP as of July 1, 2024

US$1.44 Billion

business Genus plc Company Profile

Genus plc Main Stock Listing

LSE: GNS

Market Capitalization History of Genus plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Genus plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £1.43 B -30.49%
Jan. 1, 2023 £2.06 B -19.36%
Jan. 1, 2022 £2.56 B -22.82%
Jan. 1, 2021 £3.31 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Genus plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Genus plc has the following listings and related stock indices.


Stock: LSE: GNS

Stock: FSX: GBE

Stock: OTC: GENSF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.